Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Jacobs

Showing results (21-30 of 131) with videos related to

Pageof 14
Sort By:
International Journal of Technology Assessment in Health Care|May 21, 2015
MEDICAL DEVICE PRICES IN ECONOMIC EVALUATIONSIlke Akpinar, Philip Jacobs, Don Husereau
Healthcare Management Forum|March 14, 2003
The relative cost of inpatient care in Manitoba's largest hospitalsGreg Finlayson, Diane Watson, Philip Jacobs
BMC Gastroenterology|July 6, 2007
An economic model of long-term use of celecoxib in patients with osteoarthritisMichael Loyd, Dale Rublee, Philip Jacobs
Pharmacoeconomics|March 8, 2005
Providing systematic guidance in pharmacoeconomic guidelines for analysing costsPhilip Jacobs, Arto Ohinmaa, Bruce Brady
Healthcare Management Forum|July 4, 2019
Publicly funded clinical research in CanadaIlke Akpinar, Dat T Tran, Philip Jacobs
Pharmacoeconomics - Open|July 12, 2019
The Costs of Industry-Sponsored Drug Trials in CanadaDat T Tran, Ilke Akpinar, Philip Jacobs
Spine|January 19, 2006
A population-based analysis of healthcare utilization of persons with back disorders: results from the Canadian Community Health Survey 2000-2001Kim-Lian Lim, Philip Jacobs, Scott Klarenbach
American Journal of Obstetrics and Gynecology|February 20, 2003
Use of health services associated with increased menstrual loss in the United StatesIsabelle Côté, Philip Jacobs, David C Cumming
The American Journal of Gastroenterology|June 18, 2003
Work losses related to inflammatory bowel disease in the United States: results from the National Health Interview SurveyTeresa Longobardi, Philip Jacobs, Charles N Bernstein
Healthcare Management Forum|June 20, 2020
Gross profits of Canadian pharmacies: A changing policy regimeNguyen Xuan Thanh, Philip Jacobs, Donald Husereau
Pageof 14

Showing results (21-30 of 131) with videos related to

Sort By:
Pageof 14
International Journal of Technology Assessment in Health Care|May 21, 2015
MEDICAL DEVICE PRICES IN ECONOMIC EVALUATIONSIlke Akpinar, Philip Jacobs, Don Husereau
Healthcare Management Forum|March 14, 2003
The relative cost of inpatient care in Manitoba's largest hospitalsGreg Finlayson, Diane Watson, Philip Jacobs
BMC Gastroenterology|July 6, 2007
An economic model of long-term use of celecoxib in patients with osteoarthritisMichael Loyd, Dale Rublee, Philip Jacobs
Pharmacoeconomics|March 8, 2005
Providing systematic guidance in pharmacoeconomic guidelines for analysing costsPhilip Jacobs, Arto Ohinmaa, Bruce Brady
Healthcare Management Forum|July 4, 2019
Publicly funded clinical research in CanadaIlke Akpinar, Dat T Tran, Philip Jacobs
Pharmacoeconomics - Open|July 12, 2019
The Costs of Industry-Sponsored Drug Trials in CanadaDat T Tran, Ilke Akpinar, Philip Jacobs
Spine|January 19, 2006
A population-based analysis of healthcare utilization of persons with back disorders: results from the Canadian Community Health Survey 2000-2001Kim-Lian Lim, Philip Jacobs, Scott Klarenbach
American Journal of Obstetrics and Gynecology|February 20, 2003
Use of health services associated with increased menstrual loss in the United StatesIsabelle Côté, Philip Jacobs, David C Cumming
The American Journal of Gastroenterology|June 18, 2003
Work losses related to inflammatory bowel disease in the United States: results from the National Health Interview SurveyTeresa Longobardi, Philip Jacobs, Charles N Bernstein
Healthcare Management Forum|June 20, 2020
Gross profits of Canadian pharmacies: A changing policy regimeNguyen Xuan Thanh, Philip Jacobs, Donald Husereau
Pageof 14